scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1030707189 |
P356 | DOI | 10.1186/S40644-016-0062-8 |
P932 | PMC publication ID | 4756529 |
P698 | PubMed publication ID | 26883745 |
P5875 | ResearchGate publication ID | 295097753 |
P50 | author | Julia Chalaye | Q115792942 |
Eva Evangelista | Q115792945 | ||
Alexis Laurent | Q48141150 | ||
Emmanuel Itti | Q55441652 | ||
Thomas Decaens | Q62096202 | ||
P2093 | author name string | Daniel Azoulay | |
Julien Calderaro | |||
Christophe Duvoux | |||
Alain Rahmouni | |||
Alain Luciani | |||
Frederic Pigneur | |||
Laurence Baranes | |||
Charlotte Costentin | |||
Samia Boussouar | |||
Melanie Chiaradia | |||
Shih-Jui Lin | |||
P2860 | cites work | Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging | Q22065375 |
Management of hepatocellular carcinoma: An update | Q27860530 | ||
Genotyping of hepatocellular carcinoma in liver transplant recipients adds predictive power for determining recurrence-free survival | Q73576933 | ||
Apparent diffusion coefficient measurements with diffusion-weighted magnetic resonance imaging for evaluation of hepatic fibrosis | Q81877991 | ||
Diffusion-weighted imaging of surgically resected hepatocellular carcinoma: imaging characteristics and relationship among signal intensity, apparent diffusion coefficient, and histopathologic grade | Q84263690 | ||
Combined early dynamic (18)F-FDG PET/CT and conventional whole-body (18)F-FDG PET/CT provide one-stop imaging for detecting hepatocellular carcinoma | Q86210555 | ||
Role of ¹⁸F-FDG PET CT as an independent prognostic indicator in patients with hepatocellular carcinoma | Q86830937 | ||
¹⁸F-FDG PET metabolic parameters and MRI perfusion and diffusion parameters in hepatocellular carcinoma: a preliminary study | Q28687190 | ||
Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis | Q29619508 | ||
Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C. | Q31120242 | ||
Liver cirrhosis: intravoxel incoherent motion MR imaging--pilot study | Q33384609 | ||
Apparent diffusion coefficient value of diffusion-weighted imaging for hepatocellular carcinoma: correlation with the histologic differentiation and the expression of vascular endothelial growth factor | Q33830807 | ||
Positron emission tomography scanning in the evaluation of hepatocellular carcinoma | Q33939061 | ||
Hepatocellular carcinomas in native livers from patients treated with orthotopic liver transplantation: biologic and therapeutic implications | Q34207073 | ||
Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis | Q34515064 | ||
Liver transplantation in association with hepatocellular carcinoma: an update of the International Tumor Registry | Q34802516 | ||
Hepatocellular carcinoma: epidemic and treatment | Q35739058 | ||
Tumor volume and subvolume concordance between FDG-PET/CT and diffusion-weighted MRI for squamous cell carcinoma of the cervix | Q36522127 | ||
Preoperative alpha-fetoprotein slope is predictive of hepatocellular carcinoma recurrence after liver transplantation | Q37130713 | ||
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis | Q37341959 | ||
Oncologic applications of diffusion-weighted MRI in the body. | Q37978220 | ||
Tumor response assessments with diffusion and perfusion MRI. | Q37995577 | ||
Clinical impact of PET/MR imaging in patients with cancer undergoing same-day PET/CT: initial experience in 134 patients--a hypothesis-generating exploratory study. | Q38134706 | ||
Predictability of preoperative 18F-FDG PET for histopathological differentiation and early recurrence of primary malignant intrahepatic tumors. | Q38430018 | ||
Comparison of diffusion-weighted MR imaging and FDG PET/CT to predict pathological complete response to neoadjuvant chemotherapy in patients with breast cancer | Q38471361 | ||
MRI and PET in monitoring response in lymphoma | Q39976754 | ||
Patients with non-[18 F]fludeoxyglucose-avid advanced hepatocellular carcinoma on clinical staging may achieve long-term recurrence-free survival after liver transplantation | Q43955396 | ||
Treatment response monitoring in patients with gastrointestinal stromal tumor using diffusion-weighted imaging: preliminary results in comparison with positron emission tomography/computed tomography. | Q45908631 | ||
Prediction of tumor recurrence by 18F-FDG PET in liver transplantation for hepatocellular carcinoma | Q46048048 | ||
Correlation of apparent diffusion coefficients measured by 3T diffusion-weighted MRI and SUV from FDG PET/CT in primary cervical cancer. | Q46380110 | ||
Underestimated role of 18F-FDG PET for HCC evaluation and promise of 18F-FDG PET/MR imaging in this setting | Q46454995 | ||
Diffusion-weighted MRI of lymphoma: prognostic utility and implications for PET/MRI? | Q46579579 | ||
Correlation of measurements from diffusion weighted MR imaging and FDG PET/CT in GIST patients: ADC versus SUV. | Q51527882 | ||
Assessment of tumor necrosis of hepatocellular carcinoma after chemoembolization: diffusion-weighted and contrast-enhanced MRI with histopathologic correlation of the explanted liver. | Q51791527 | ||
Reply: Underestimated role of 18F-FDG PET for HCC evaluation and promise of 18F-FDG PET/MR imaging in this setting. | Q53102653 | ||
Diffusion weighted MRI and 18F-FDG PET/CT in non-small cell lung cancer (NSCLC): does the apparent diffusion coefficient (ADC) correlate with tracer uptake (SUV)? | Q53183858 | ||
Diffusion-weighted MRI in early chemotherapy response evaluation of patients with diffuse large B-cell lymphoma--a pilot study: comparison with 2-deoxy-2-fluoro- D-glucose-positron emission tomography/computed tomography. | Q53239547 | ||
Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome. | Q53350866 | ||
Can microvessel invasion of hepatocellular carcinoma be predicted by pre-operative MRI? | Q53515473 | ||
Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression | Q57000083 | ||
Liver Transplantation for Hepatocellular Carcinoma: A Model Including α-Fetoprotein Improves the Performance of Milan Criteria | Q63190284 | ||
In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET | Q71749192 | ||
P921 | main subject | hepatocellular carcinoma | Q1148337 |
liver transplantation | Q1368191 | ||
Fluorodeoxyglucose Positron Emission Tomography/ Computed Tomography | Q130273251 | ||
P304 | page(s) | 4 | |
P577 | publication date | 2016-02-16 | |
P1433 | published in | Cancer Imaging | Q2577267 |
P1476 | title | Functional imaging of hepatocellular carcinoma using diffusion-weighted MRI and (18)F-FDG PET/CT in patients on waiting-list for liver transplantation | |
P478 | volume | 16 |
Q89701966 | Clinical usefulness of FDG-PET in patients with hepatocellular carcinoma undergoing surgical resection |
Q58604547 | Clinical, Epidemiological and Histopathological Aspects in Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation |
Q42085639 | Diffusion weighted magnetic resonance imaging of liver: Principles, clinical applications and recent updates |
Q64078084 | F-fludeoxyglucose positron emission tomography for diagnosis of HCC: implications for therapeutic strategy in curative and non-curative approaches |
Q88791892 | Hepatocellular carcinoma: when is liver transplantation oncologically futile? |
Q58583425 | Microvascular Invasion in HCC: The Molecular Imaging Perspective |
Q58584963 | Multiparametric FDG-PET/MRI of Hepatocellular Carcinoma: Initial Experience |
Q40974763 | Quantitative assessment of simultaneous F-18 FDG PET/MRI in patients with various types of hepatic tumors: Correlation between glucose metabolism and apparent diffusion coefficient |
Q58566698 | Role of pre-transplant 18F-FDG PET/CT in predicting hepatocellular carcinoma recurrence after liver transplantation |
Search more.